IRL757 finishes Ph 1 in 65+ healthy adults
Today IRLAB announced positive topline results from IRL757 in healthy adults aged 65 and older. Most importantly, the study confirmed the drug candidate's favourable PK, safety and tolerability profile observed already in part 1 of the study in healthy younger adults. The study was part of the collaboration with MSRD.
Aktuellt
SENASTE
